- Home
- RGNX vs UIS Comparison
RGNX vs UIS Comparison
Compare RGNX & UIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGNX
- UIS
- Stock Information
- Founded
- RGNX 2008
- UIS 1942
- Country
- RGNX United States
- UIS United States
- Employees
- RGNX N/A
- UIS N/A
- Industry
- RGNX Biotechnology: Biological Products (No Diagnostic Substances)
- UIS EDP Services
- Sector
- RGNX Health Care
- UIS Technology
- Exchange
- RGNX Nasdaq
- UIS Nasdaq
- Market Cap
- RGNX 459.1M
- UIS 474.3M
- IPO Year
- RGNX 2015
- UIS N/A
- Fundamental
- Price
- RGNX $9.18
- UIS $7.80
- Analyst Decision
- RGNX Strong Buy
- UIS
- Analyst Count
- RGNX 12
- UIS 0
- Target Price
- RGNX $36.36
- UIS N/A
- AVG Volume (30 Days)
- RGNX 886.8K
- UIS 873.2K
- Earning Date
- RGNX 11-06-2024
- UIS 10-29-2024
- Dividend Yield
- RGNX N/A
- UIS N/A
- EPS Growth
- RGNX N/A
- UIS N/A
- EPS
- RGNX N/A
- UIS N/A
- Revenue
- RGNX $84,327,000.00
- UIS $2,020,600,000.00
- Revenue This Year
- RGNX $7.91
- UIS $0.92
- Revenue Next Year
- RGNX $214.75
- UIS $2.90
- P/E Ratio
- RGNX N/A
- UIS N/A
- Revenue Growth
- RGNX N/A
- UIS 0.29
- 52 Week Low
- RGNX $8.54
- UIS $3.32
- 52 Week High
- RGNX $28.80
- UIS $8.49
- Technical
- Relative Strength Index (RSI)
- RGNX 43.02
- UIS 60.38
- Support Level
- RGNX $8.87
- UIS $7.13
- Resistance Level
- RGNX $12.11
- UIS $8.42
- Average True Range (ATR)
- RGNX 0.96
- UIS 0.37
- MACD
- RGNX -0.05
- UIS -0.06
- Stochastic Oscillator
- RGNX 17.17
- UIS 49.26
About RGNX REGENXBIO Inc.
Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.
About UIS Unisys Corporation New
Unisys Corp is engaged in the provision of technology solutions for clients across the government, financial services, and commercial markets. It operates through three business segments: Digital Workplace Solutions (DWS),Cloud, Applications & Infrastructure Solutions (CA&I), and Enterprise Computing Solutions (ECS). DWS provides solutions that transform digital workplaces securely and create exceptional end-user experiences. CA&I provides digital platform, applications and infrastructure solutions. ECS provides solutions that harness secure, continuous high-intensity computing and enable digital services through software-defined operating environments.